Presentation, Characteristics and Co-morbidities of Men with Prostate Cancer in Nigeria
Chimaobi Gideon Ofoha, Felix Echebiri Magnus
Journal of Advances in Medicine and Medical Research · pp. 1–7 · Published 2 Dec 2019
10.9734/jammr/2019/v31i530297Abstract
Aims: To determine the presentation, characteristics and associated co-morbidities in Nigerian men with prostate cancer. Study Design: Retrospective study. Place and Duration of Study: The study was carried at the Division of Urology, Department of Surgery, Jos University Teaching Hospital, Jos, Nigeria from January 2010 to December 2018. Methodology: Men with histologically confirmed prostate cancer were analyzed. The age of the men, PSA pattern, histologic type, Gleason score, stage of the disease, associated co-morbidities and treatment received by the men were recorded. The effect of co-morbidities on disease aggressiveness using Gleason score and PSA as determinants was determined using Pearson correlation. SPSS version 23 was used in analyzing the data. P-value of < 0.05 was considered significant. Results: Eighty-one patients with prostate cancer from 2010 to 2018 were involved in the study. The mean age was 67.58±9.42 years with a range of 42 to 96years. Men with PSA >100 ng/ml had the highest frequency (34.60%). The mean Gleason Score was 6.28±2.13. Gleason score 7-8 had the highest frequency (35.8%). Seventy-nine patients (97.5%) had adenocarcinoma. Eighty-one percent of the men had advanced Pca, 58% being metastatic disease. 48.1% had co-morbidities, 39.5% had hypertension, while 8.6% had both hypertension and diabetes. Comorbidities showed no correlation with PSA level (r=0.346), (p-value 0.375) and Gleason score (r=0.194), (p-value 0.639). Seventy-nine percent of the men had androgen deprivation therapy. Conclusion: Most of the men presented with advanced disease, with all indices pointing towards lethal disease. The commonest co-morbidity was hypertension and co-morbidities had no relationship with the aggressiveness of prostate cancer. To ensure early presentation and prevent lethal forms of Pca, health education, screening, counselling for men in the high-risk group is paramount.
Cited by 11
Abbas A Abdus-Salam, Mutiu A Jimoh, Ayorinde M Folasire · ecancermedicalscience · 2024
Musliu Adetola Tolani, Sathishrajaa Palaniraja, Zaharaddeen Shuaibu Babandi · European Journal of Surgical Oncology · 2025
Sossa Jean, Fanou Lionelle, Hounto Yao Félicien · Open Journal of Urology · 2023
Ayodeji Olusola Ogunmola, Adedayo S.A. Oyedeji, Oluseyi O. Fadahunsi · Journal of West African College of Surgeons · 2024
Akin Osibogun, Mobolanle Balogun, Akin Abayomi · PLOS ONE · 2021
Essonan Kadanga, Abdou Azaque Zouré, Théodora M. Zohoncon · BMC Medical Genomics · 2022
Michael Yan, Andre G. Gouveia, Fabio L. Cury · Nature Reviews Urology · 2021
Chinonyerem O. Iheanacho, Valentine U. Odili, Glen E. Enakirerhi · American Journal of Men's Health · 2024
Chinonyerem O. Iheanacho, Okechukwu H. Enechukwu · Cancer Causes & Control · 2024
Nasiru Raheem, Aminu M C Dahiru · Nigerian Journal of Medicine · 2021
Related research
- Awareness of Causes and Health Risks Associated with High Blood Cholesterol among Men in Awka Etiti, Anambra State, Nigeria — shares topic coverage
- Loss of Autonomic Nervous System Control of Blood Pressure in Patients with Parkinson’s Disease — shares topic coverage
- Monomorphic T-Cell Post-Transplant Lymphoproliferative Disorder: A Case Report — shares topic coverage
- A Case of Ventilator Associated Pneumonia Caused by Pannonibacter phragmitetus — shares topic coverage
- The Impact of Obesity on Prostate Cancer Aggressiveness: A Retrospective Analysis in Kiambu County, Kenya — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
11
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.